Inhibrx Announces Execution of Merger Agreement
Market News

Inhibrx Announces Execution of Merger Agreement

Inhibrx (INBX) has released an update to notify the public and investors about a regulation fd disclosure.

On January 23, 2024, the Company announced the execution of a Merger Agreement through a press release. The details provided in the press release and this report are not considered “filed” under the Securities Exchange Act of 1934 and are not subject to its liabilities, nor will they be included in any filings unless explicitly referenced.

For further insights into INBX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyInhibrx prevails in trade secret case with I-Mab
TheFlyInhibrx management to meet virtually with Jefferies
TipRanks Auto-Generated NewsdeskInhibrx Biosciences Reveals Updated Corporate Presentation
Go Ad-Free with Our App